Comment on Matsota et al.
Butler
Patrick
P
D000759:Adjuvants, Anesthesia / Q000627:therapeutic use; D000310:Adrenal Gland Neoplasms / Q000601:surgery*; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000097:blood / Q000627:therapeutic use*; D000768:Anesthesia, General; D002675:Child, Preschool; D006801:Humans; D008278:Magnesium Sulfate / Q000097:blood / Q000627:therapeutic use*; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000601:surgery*; D014673:Vecuronium Bromide / Q000627:therapeutic use
D000759:Adjuvants, Anesthesia; D000317:Adrenergic alpha-Antagonists; D000700:Analgesics; D009467:Neuromuscular Depolarizing Agents; D008278:Magnesium Sulfate; D014673:Vecuronium Bromide